FFOX - ETF AI Analysis

Top Page

FundX Future Fund Opportunities ETF (FFOX)

Rating:65Neutral

Price Target:―

FFOX, the FundX Future Fund Opportunities ETF, has a solid overall rating driven mainly by strong holdings like Globus Medical and Onto Innovation, which benefit from healthy financial performance, positive earnings commentary, and supportive technical trends. Additional contributors such as TechnipFMC, Advanced Drainage Systems, and InterDigital add to the fund’s quality through solid growth, profitability, and strategic initiatives. However, weaker positions like Green Plains, Ionis Pharmaceuticals, and Guardant Health, which face financial and profitability challenges, introduce risk and slightly hold back the fund’s overall standing.

Positive Factors

Strong Recent Performance

The ETF has shown steady gains over the past month, three months, and year to date, indicating positive recent momentum.

Leading Holdings With Strong Gains

Several of the top positions, such as TechnipFMC, Green Plains, Onto Innovation, and Millicom, have delivered strong year-to-date performance that supports the fund’s returns.

Broad Sector Diversification

Holdings are spread across multiple sectors like industrials, technology, health care, and consumer-related industries, which helps reduce reliance on any single part of the market.

Negative Factors

High Expense Ratio

The fund’s expense ratio is relatively high for an ETF, which means more of the returns are used to cover fees instead of going to investors.

Heavy U.S. Concentration

With the vast majority of assets invested in U.S. companies, the ETF offers limited geographic diversification and is highly tied to the U.S. market’s fortunes.

Exposure to Lagging Holding

One of the top holdings, Guardant Health, has shown weak year-to-date performance, which can drag on overall fund results if the stock continues to struggle.

FFOX vs. SPDR S&P 500 ETF (SPY)

AUM203.89M

RegionNorth America

Expense Ratio1.02%

Beta0.95

IssuerFundX

Inception DateJun 10, 2025

Dividend Yield1.76%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume17,045

30 Day Avg. Volume18,808

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

35.30

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering74

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

FFOX Summary

The FundX Future Fund Opportunities ETF (FFOX) is an actively managed fund that looks for small- and mid-size companies expected to benefit from big long-term trends like new technology, sustainability, and aging populations. It doesn’t track a set index, but instead picks stocks across many sectors, mainly in the U.S., including technology, health care, and industrials. Well-known holdings include Globus Medical and Ionis Pharmaceuticals. Someone might invest for growth and diversification across several future-focused themes. A key risk is that these smaller, trend-focused stocks can be volatile and may go up and down more than the overall market.

How much will it cost me?The FundX Future Fund Opportunities ETF (FFOX) has an expense ratio of 1.00%, meaning you’ll pay $10 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on identifying and investing in sectors aligned with transformative global trends.

What would affect this ETF?FFOX's focus on transformative megatrends like technology and healthcare positions it to benefit from advancements in innovation and demographic shifts, which could drive long-term growth. However, its exposure to small- and mid-cap companies may make it more sensitive to economic downturns or interest rate hikes, which can negatively impact these sectors. Additionally, regulatory changes in healthcare or technology could pose risks to its top holdings.

FFOX Top 10 Holdings

FFOX is leaning into future-focused themes with a U.S.-heavy mix of industrials, tech, and health care names. Onto Innovation and TechnipFMC have been doing much of the heavy lifting lately, with rising share prices that give the fund a helpful tailwind. Millicom and Advanced Drainage Systems are also pulling their weight with steady to rising performance. On the flip side, Guardant Health has been dragging the fund, and Ionis Pharmaceuticals looks more mixed, reminding investors that this small- and mid-cap growth hunt comes with some bumps along the way.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
	―	5.25%	$10.71M	―	―	―
FTI	TechnipFMC	2.88%	$5.87M	$25.78B	144.92%	80 Outperform
TIGO	Millicom International Cellular SA	2.72%	$5.54M	$11.87B	151.86%	71 Outperform
GMED	Globus Medical	2.25%	$4.59M	$12.06B	17.01%	82 Outperform
IONS	Ionis Pharmaceuticals	2.17%	$4.43M	$12.42B	118.55%	61 Neutral
WMS	Advanced Drainage Systems	2.09%	$4.25M	$11.61B	31.37%	74 Outperform
GPRE	Green Plains	2.04%	$4.16M	$1.08B	162.88%	56 Neutral
GH	Guardant Health	2.04%	$4.16M	$12.14B	130.47%	61 Neutral
ONTO	Onto Innovation	1.78%	$3.62M	$9.79B	46.66%	82 Outperform
HALO	Halozyme	1.77%	$3.62M	$7.95B	11.99%	73 Outperform

FFOX Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

28.52

Negative

100DMA

28.11

Negative

200DMA

Market Momentum

MACD

<0.01

Positive

RSI

41.93

Neutral

STOCH

32.62

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FFOX, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 28.67, equal to the 50-day MA of 28.52, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 41.93 is Neutral, neither overbought nor oversold. The STOCH value of 32.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FFOX.

FFOX Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
FFOX	―	―	$203.89M	1.02%	65 Neutral
FEPI	―	―	$585.66M	0.65%	73 Outperform
SAMT	―	―	$487.69M	0.65%	61 Neutral
AIPI	―	―	$369.72M	0.65%	71 Outperform
DUNK	―	―	$123.29M	0.75%	73 Outperform
LFGY	―	―	$101.26M	1.02%	58 Neutral

Performance Comparison

FFOX

FundX Future Fund Opportunities ETF

28.03

2.84

11.27%

FEPI

REX FANG & Innovation Equity Premium Income ETF

―

SAMT

Strategas Macro Thematic Opportunities ETF

―

AIPI

REX AI Equity Premium Income ETF

―

DUNK

Dana Unconstrained Equity ETF

―

LFGY

YieldMax Crypto Industry & Tech Portfolio Option Income ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents